(Date:11/25/2009)...,, DURHAM,N.C.,Nov.25/PRNewswire/--ResearchTr...fficient,single-treatmentwaterpurificationsystemNa...esh,MinisterofRuralWaterSupply,Hon.MinisterViswaru...s,performedatIndianInstituteofTechnology(IIT)Kanpu...bleinIndiacontainstoxinsthatcanbeextremelyhazardou...
(Date:11/25/2009)...,, MARKHAM,ON,Nov.25/PRNewswire/-Cytochromato...rdofDirectors.Dr.MoldtwillreplaceMr.UlrikSporkasth...rofBoardmembersremainsunchangedatsixmembers. ,,...lookforwardtobenefitingfromhisexperienceandguidanc...dingCKD-focusedspecialtypharmaceuticalcompany,"sta...
(Date:11/24/2009)... This release is available in German . , ...ation cards: RFID tags (Radio Frequency Identifica...yday life. They make it possible to label objects ...frequency. The appropriate scanner can read and pr...s can be affixed to goods under production conditi...
(Date:11/24/2009)...,, SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomo...,thenation,sleadingonlinejobboardandcareerssitefor...umbiaUniversityarenowmembersofthejobboard,joining2...Thejobboard, www.biocareercenter.com ,isonlyforpos...oflifesciencecareersitesontheInternet,BioCareerCen...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2... PRINCETON, N.J., Feb. 5 Sopherion Therapeutics, ...velopment and commercialization of anti-cancer the...om a phase I/II study of nonpegylated liposomal do...linical Cancer Research . The study was supported...anish Breast Cancer Cooperative Group (SOLTI). , ...
... SEATTLE, Feb. 5 Cell Therapeutics (CTI),(Nas...ued 6,634 shares of,Series F Preferred Stock in ex... Convertible Preferred Stock. The exchange constit...tible Preferred Stock. Each share of the new Prefe...es of CTI,s common stock, at a,conversion price of...
... SAN MATEO, Calif., Feb. 4 NeurogesX, Inc. (Nasda...n developing and commercializing novel pain manage...no, President and Chief Executive Officer, is sche...Investor Conference in New York City on Tuesday, F...i, Chief Financial Officer, will also be available...
Other Biology Technology:Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 2Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 3Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 4Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 3...leader in electroporation products and specialty e...uct line for experiment optimization and large vol...System is a breakthrough in Molecular Delivery. Th...ti-step procedures that typically limited the numb...
...Screening Sets contain the basic components and pr...ich ELISA plates for quantitation of a specific pr...ry Screening Set contains Coating and Detection An...ards), Streptavidin-HRP, TMB Substrate Solution (o...
...en Progesterone Receptor (PR) Competitor Assay Kit...terone receptor binding compounds using fluorescen...s a fusion of glutathione transferase to the ligan...R-LBD(GST)] and a proprietary, fluorescently tagge...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
Biology Products: